PD-1/PDL-1 inhibitors - Keratoacanthoma potential signal

PD-1/PDL-1 inhibitors potential signal

As of Dec 2022, several Keratoacanthoma reports were in the FAERS database for PD-1/PDL-1 inhibitors. There was only one report for atezolizumab, and the PRR was low. The rest of the drugs have PPR mostly above 2. Only reports with the specific primary suspect drug are included in the output. Further analysis is required to confirm the potential signal.

DiscoverAE output:

PD-1/PDL-1 inhibitors potential signal